The aim of this study was to characterise the mechanism of TGF-β1 mediated alteration of renal proximal tubular cell phenotype. TGF-β1 altered cell phenotype with cells appearing elongated and spindle shaped.
INTRODUCTION
It is now clear that in all renal diseases, the progression of renal insufficiency is closely correlated to the degree of renal interstitial fibrosis (4, 20) . This has led to the hypothesis that tubulointerstitial fibrosis is the common final pathway leading to end-stage renal failure. With increasing awareness of the importance of these pathological interstitial changes, interest has focused on the role of cells, such as the epithelial cells of the proximal tubule (PTC), in the initiation of a fibrotic response.
Transforming Growth Factor ß (TGF-ß) which is the prototypic member of the TGF-ß1 super-family exerts a broad range of biological activities. There is overwhelming evidence implicating TGF-ß in the pathogenesis of progressive renal fibrosis associated with numerous diseases. In addition to its role in the modulation of extracellular matrix turnover, studies utilising normal rat kidney tubular epithelial cells suggest that TGF-ß1 may be a key mediator regulating differentiation of tubular epithelial cells into α-SMA positive cells (11) . Furthermore, recent studies using intermediate filament markers and reorganisation of the cytoskeleton as indicators of a "fibroblastic" phenotype, suggest that TGF-ß1 induce phenotypic alterations in renal proximal tubular epithelial cells. The mechanism by which TGF-ß1 regulate cell phenotype is, however, not clear.
TGF-ßs elicit their signalling effects by binding mainly to three cell-surface receptors: type I (RI), type II (RII) and type III (RIII). RI and RII are serine/threonine kinases that form heteromeric complexes, and are necessary for TGF-ß signalling. Ligand binding induces assembly of a heteromeric complex, which results in activation of the signalling intermediates, Smads, and initiation of transcriptional activation of target genes. Although the Smad proteins are key participants in TGF-ß1 signalling, other signalling pathways are known to be activated by TGF-ß1 (10, 14) . We have recently characterised TGF-ß1 mediated disassembly of PTC cell-cell junctional complexes, and demonstrated a link between the TGF-ß type II receptor/Smad pathway and alterations ß-catenin/E-cadherin phosphorylation (44) . These results together with recent studies suggesting co-operative effects in terms of cell signalling mediated by the TGF-ß1 and Wnt pathways (17) suggest that the Wnt pathway may be a further potential signalling pathway mediating downstream events following TGF-ß1-receptor binding. Although the Smad proteins are key participants in TGF-ß1 signalling, other signalling pathways have also been shown to be activated by TGF-ß1. For example recent studies in a fibrosarcoma cell line have demonstrated induction of fibronectin transcription and synthesis to be dependent TGF-ß1 mediated activation of c-Jun N-terminal kinase (JNK) a member of the MAP kinase family (14) . 4 The aim of the current study was to examine the mechanism by which PTC phenotype is altered in response to TGF-ß1. We have characterised the relative contributions of alteration in cell-cell contact and the role of cell-matrix interaction in regulation of cell phenotype. In addition we examined the involvement numerous potential signalling pathways in mediating these effects. These data suggest that acquisition of a "fibroblastic" phenotype in response to TGF-ß1 required co-ordinated alterations in the cytoskeleton, and disruption of cell-cell and cell-matrix interactions. Furthermore this is not dependent on Smad or Wnt signalling but rather is dependent on activation of the RhoA-ROCK pathway.
EXPERIMENTAL PROCEDURES
Materials. Antibodies for western blot analysis, immunoprecipitation, and immunocytochemistry and the final working dilution were as follows:
For western blot analysis:
• mouse monoclonal anti-E-cadherin antibody (dilution 1:1500) from Transduction Laboratories (Lexington, KY, USA)
• rabbit monoclonal anti-ß-catenin antibody (dilution 1:1500) from Transduction Laboratories (Lexington, KY, USA)
• mouse monoclonal anti-paxillin antibody (dilution 1:500) from Biognostics (Wybsoton, Bedfordshire,
UK)
• mouse monoclonal anti-FLAG antibody (dilution 1:500) from Sigma (Poole, UK)
• mouse monoclonal anti-RhoA antibody (dilution 1:400) from Santa Cruz Biotechnology, Inc. (Wiltshire,
• Rhotekin Rho binding domain (recombinant protein expressed in E. coli) from Upstate Biotechnology Inc. (Buckinghamshire, UK)
• mouse monoclonal anti-phosphotyrosine antibody for immunoprecipitation (dilution 1:100) from Sigma (Poole, UK)
• all of HRP-conjugated secondary antibodies from Sigma (Poole, UK)
For immunocytochemistry:
• rabbit monoclonal anti-ß-catenin antibody (dilution 1:100) from Transduction Laboratories (Lexington, KY, USA)
• rabbit monoclonal anti-occludin antibody (dilution 1:100) from Zymed Laboratories Inc (San Francisco)
• mouse monoclonal anti-vinculin antibody (dilution 1:100) from Sigma (Poole, UK)
• mouse monoclonal anti-paxillin antibody (dilution 1:100)
• mouse monoclonal anti-ß3-integrin antibody (dilution 1:50) Upstate Biotechnology Inc (Buckinghamshire, UK)
• anti-FLAG monoclonal antibody (dilution 1:100) from Sigma (Poole, UK)
• mouse TRITC-conjugated phalloidin antibody (dilution 1:50) from Sigma (Poole, UK)
• all of FITC-conjugated secondary antibodies from Sigma (Poole, UK)
Other reagents
• Recombinant TGF-ß1 was purchased from R&D Systems (Oxford UK)
• Cytochalasin D from Sigma (Poole, UK)
• tyrosine phosphatase inhibitor, sodium orthovanadate, from Calbiochem (San Diego, California, USA)
• the inhibitors of RhoA target-protein Rho-associated coiled-coil kinase (ROCK) R-(+)-trans-N-(4- transferrin and sodium selenite (Sigma, Poole, UK). Cells were grown at 37 °C in 5% CO2 and 95% air.
Fresh growth medium was added to cells every 3-4 days until confluent. Cells were grown to confluence and serum deprived for 48 hours prior to experimental manipulation. All experiments were performed under serum free conditions. Selective experiments with primary human proximal tubular epithelial cells (HPTC) were performed to confirm the observations obtained in HK2 cells. HPTC were isolated from normal tissue obtained from nephrectomy specimens, characterised as previously described (31) and grown under the same culture conditions as HK2 cells.
The effects of TGF-ß on cell phenotype were determined by addition of recombinant cytokine (0-50ng/ml) to confluent growth arrested monolayers of cells. All experiments were performed under serum free conditions. Cell phenotype was monitored by light microscopy. In all experiments, supernatant 6 samples were collected and stored at -70°C. Subsequently cell protein was prepared as described below.
For all experiments a known number of cells were seeded into each flask, and all results were normalised for this cell number. Similarly for western blot analysis equal amount of total protein was loaded as assessed by the Bradford protein assay (Bio-Rad laboratories Ltd, Hertfordshire, UK). Double immunofluorescence was performed to examine stress fibre organisation resultant from Smad over-expression. Fixation and a blocking step as described above cells were incubated with TRITCconjugated phalloidin and FITC conjugated anti-FLAG monoclonal antibody for 1hour at room temperature prior to addition of appropriate secondary antibody.
Immunohistochemistry

Alteration in E-cadherin expression;
Total cell lysates were obtained by washing cells once with cold PBS; cells were subsequently detached by scraping into 5ml cold PBS. After centrifugation at 2,500 rpm for 10 minutes, cell pellets were mixed with sodium dodecyl sulfate (SDS) sample buffer (reducing sample buffer) and stored at 20°C until use.
Immunoblot analysis of lysate samples was performed by standard methodologies. Tyrosine phosphorylation of E-cadherin was examined by E-cadherin immunoblot analysis, following phosphotyrosine immunoprecipitation performed by standard methodologies. Briefly cell protein samples were pre-cleared with 50µl packed protein A cross linked 4% beaded agarose (Sigma, Poole, U.K.) at 4°C for 1 hour. The beads were removed by centrifugation (13.000 rpm, 10 min) and the supernatant collected.
Primary antibody (2µg/ml) was added to the cleared supernatant and incubated at 4°C with constant mixing for 12h. The immune complex was captured by the addition of packed agarose protein A beads (50µl /500µl supernatant) for 2 hours at 4°C. Separation of the beads was achieved by centrifugation (13 7 000xg for 25mins) and the supernatant removed. Specificity of immunoprecipitation was confirmed by negative control reactions performed with either no primary antibody, or rabbit IgG control.
Detection of focal adhesion proteins. Association of focal adhesion components and adherens junction proteins with the actin cytoskeleton was indirectly assessed by examining their triton solubility as previously described (2) . Using this method the Triton-soluble component represents membrane and cytosolic fractions and not proteins associated with the cytoskeleton. Following seeding of equal number of cells, confluent monolayers were washed once with cold PBS, scraped and rinsed into 5ml cold PBS.
After centrifugation at 2,500 rpm for 10 minutes, cells pellets were extracted in buffer (150 mM NaCl, 50
mM Tris-Cl, 0.01% NaN3, 2 mM EDTA, 1 mM sodium orthovandadate, 10 µg/ml leupeptin, 25 ug/m aprotinin) containing 1% Triton X-100 (TX buffer) for 30 minutes on ice. Samples were centrifuged at 12,500 rpm for 30 minutes and then the supernatant (Triton-soluble component including membrane and to GTP-Rho, not GDP-Rho to precipitate GTP-Rho, followed by immunoblotting with specific RhoA antibody, we are able to detect the activity of activated RhoA, GTP-RhoA. This method has been well established to measure activated RhoA activity. Briefly, following addition of TGF-β1 (10ng/ml) for 2 hours or 2 days, cell monolayer was rinsed twice with ice-cold Tris-Buffered Saline (TBS). Cell lysate was obtained by adding Mg 2+ buffer (25mM HEPES, pH 7.5, 150mM NaCl, 1% Igepal CA-630, 10mM
MgCl 2 , 1mM EDTA and 10% glycerol) onto cell monolayer and scraping with cell scraper, followed by centrifugation at 14,000g for 5 minutes at 4°C. Supernatant was transferred to a microfuge tube and further incubated with 30µg of rhotekin RBD-agarose slurry for 45 minutes at 4°C. Agarose beads were then pelleted by brief centrifugation, washed with Mg2+ buffer three times, and subjected to western blot analysis as described above. Activated GTP-RhoA was detected by immunoblotting with specific RhoA antibody.
RESULTS
Morphological alterations.
The culture of HK2 cells in six well plates or eight chamber glass slides produced a confluent monolayer with cobblestone morphology ( Figure 1A ). Serum deprivation to achieve cell cycle synchronisation did not alter cell morphology. In contrast addition of recombinant TGF-ß1 In addition to an alteration in cell-cell contact, TGF-ß1 mediated alteration in cell phenotype was also associated with alteration in cell-matrix interactions, as TGF-ß1 induced the expression of paxillin and vinculin and their incorporation into dense focal adhesion plaques ( Figure 3 ). There was also an increase in ß3 integrin associated with these dense adhesion plaques ( Figure 3 ).
Tyrosine phosphorylation of E-cadherin is known to critically regulate adherens junction protein complex assembly and we have demonstrated that loss of cell-cell contact in response to TGF-ß1 is associated with E-cadherin phosphorylation and adherens junction disassembly manifested by relocation of ß-catenin away from the cell periphery. We used the tyrosine phosphatase inhibitor sodium orthovanadate to determine if E-cadherin phosphorylation and adherens junction disassembly, regulate cell phenotype.
Addition of sodium orthovanadate resulted in transient loss lost cell-cell contact ( Figure 4A ). Loss of cellcell contact was also accompanied by transient increase in tyrosine phosphorylation of E-cadherin without change total E-cadherin expression ( Figure 4C ) and re-localisation of the adherens junction component ß-catenin from the cell periphery ( Figure 4B ). The time course of loss of cell-cell contact was however very Although TGF-ß1 mediated alteration in cell morphology was prevented by inhibition of ROCK, Y27632
did not prevent TGF-ß1 stimulation of type IV collagen synthesis ( Figure 9 ).
In contrast to inhibition of RhoA downstream targets, inhibitors of PI3-kinase (LY284002;
Calbiochem), p38 MAP kinase (SB202580; Calbiochem) or MAP kinase kinase/MEK (PD98059 Calbiochem) did not influence TGF-ß1 mediated alteration in cell phenotype, nor any of the associated rearrangement of adherens junction, tight junction or focal adhesion components (data not shown).
DISCUSSION
The clinical course of patients with of renal insufficiency can be predicted by the extent of fibrosis in the cortico-interstitium (20, 21) , and a large body of evidence supports a role for TGF-ß1 in its The predominant cell type in the renal cortex is the PTC and numerous studies have identified the PTC as a major potential source of pro-fibrotic growth factors such as TGF-ß1 (24, 31, 33, 37) . A further mechanism, by which PTC may influence the renal corticointerstitium, is that they may acquire a fibroblastic phenotype, as assessed by the expression of fibroblast specific markers in vitro and in vivo (42) . De novo expression of α-smooth muscle actin (α-SMA), a marker of myofibroblast phenotype, by PTC, may be associated with disruption of the tubular basement membrane and migration of these cells into the corticointerstitium (27) , a process which may be mediated by TGF-ß1. Therefore through a This does not rule out the possibility that a competent Smad pathway is required, together with a second signalling pathway to induce phenotypic change. Such co-operative effects have been described during malignant phenotypic changes (29) . We have demonstrated the efficacy of the expression both in terms of over-expression of Smad protein and also their functionality as type IV collagen synthesis and TGF-ß1 promoter transcriptional activity were stimulated in transiently transfected cells. Despite stimulation of TGF-ß1 promoter activity, we were unable to detect alteration in TGF-ß1 protein production in Smad-over-expressing cells. This may suggest that either TGF-ß1 levels were too low for detection by ELISA, or that despite transcriptional activation of the TGF-ß1 gene, that there was no de novo protein synthesis, consistent with previous studies which have demonstrated independent regulation of TGF-ß transcription and translation in proximal tubular cells (12, 24, 31, 33) . In addition TGF-ß1 is produced almost exclusively in its latent form by these cells (30, 32) , and thus without activation, even stimulation of TGF-ß1 synthesis would not be expected to result in its generation in a biological active form. Furthermore TGF-ß1 mediated translocation of Smad4 into the nucleus occurred as early as 2 hours following its addition to cells, while alteration in cell morphology was only apparent after 2 days, suggesting that a Smad signalling pathway does not affect cell morphological change directly. This is consistent with recent published studies of mammary epithelial cell differentiation in which TGF-ß1 alterations in cell morphology were not Smad dependent (3) .
We have previously demonstrated that TGF-ß1 leads to loss of PTC cell-cell contact and disassembly of adherens junctional protein complexes, with release of ß-catenin from the complex (44).
There is a large body of evidence to support a cadherin-independent role for ß-catenin. This involves translocation of ß-catenin to the nucleus, which is preceded by its accumulation in the cytoplasm.
Alteration in ß-catenin phosphorylation status is known to influence binding to E-cadherin and the regulation of cell-cell contact, ß-catenin degradation via the ubiquitin-proteasome pathway and is also a mechanism which regulates ß-catenin transcription factor recognition and binding (1, 26, 34, 40) . Our previous studies demonstrating TGF-ß1 induced stimulation of ß-catenin tyrosine phosphorylation therefore suggest that this may also facilitate cadherin independent ß-catenin dependent signalling. The
Wnt pathway is distinct from that of TGF-ß and is mediated by ß-catenin, however several recent studies have shown that co-operation may exist between TGF-ß1 and Wnt/ß-catenin pathways. This may occur both by interactions of intracellular proteins of both pathways facilitating translocation into the nucleus (28) , and also by co-operative regulation of target gene within the cell nucleus (19) . Although TGF-ß1
stimulates the interaction between the TGF-ß1 signalling intermediates Smad3 and 4, and ß-catenin within the cytoplasm in PTC, the data in the current manuscript suggest that this does not lead to co-operative activation of Wnt target gene expression as the Xtwn promoter containing both SBE and LEF1 binding sites, was unaffected by stimulation by TGF-ß1. In addition there was no alteration in Topflash, which does not contain SBE, thus confirming the lack of stimulation of Xtwn target genes. Previous studies have suggested that renal epithelial cell Wnt unresponsiveness may be the result of lack of expression of LEF-1 related proteins in this cell type (13) . Furthermore studies of renal fibrosis of diverse aetiology have suggested that increased Wnt expression may be confined to areas of fibrosis surrounding the collecting ducts predominantly in the renal medulla (43) . Over-expression of LEF-1 in PTC although stimulating exogenous Wnt target genes (Xtwn and Topflash), did not however influence PTC morphology or function. This suggests that this pathway was not involved in TGF-ß1 mediated signalling at least in this cell type. It is interesting to speculate however that Smad-ß-catenin interactions may be involved in Promoter activity was expressed as the "fold increase" in luciferase concentration compared to transfection with reporter construct alone, normalised to ß-galactosidase activity, and is expressed as the mean ± SD of a minimum of three separate experiments. 
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